Canadian-American physician and pharmacologist (1914?2015)
Frances Oldham Kelsey
|
---|
|
Born
| Frances Kathleen Oldham
(
1914-07-24
)
July 24, 1914
|
---|
Died
| August 7, 2015
(2015-08-07)
(aged 101)
|
---|
Citizenship
|
- Canada
- United States (from 1950s)
|
---|
Alma mater
| |
---|
Occupation
| Pharmacologist
|
---|
Known for
| Preventing
thalidomide
from being marketed in the United States
|
---|
Spouse
|
Fremont Ellis Kelsey
(
m.
; died 1966)
|
---|
Children
| 2
|
---|
Medical career
|
Field
| Physician
|
---|
Awards
| President's Award for Distinguished Federal Civilian Service
(1962)
|
---|
|
Frances Kathleen Oldham Kelsey
CM
(
nee
Oldham; July 24, 1914 ? August 7, 2015) was a Canadian-American
[1]
pharmacologist
and physician. As a reviewer for the U.S.
Food and Drug Administration
(FDA), she refused to authorize
thalidomide
for market because she had concerns about the lack of evidence regarding the drug's safety.
[2]
Her concerns proved to be justified when it was shown that thalidomide caused serious
birth defects
. Kelsey's career intersected with the passage of laws strengthening FDA oversight of
pharmaceuticals
. Kelsey was the second woman to receive the
President's Award for Distinguished Federal Civilian Service
, awarded to her by
John F. Kennedy
in 1962.
Birth and education
[
edit
]
Born in
Cobble Hill, British Columbia
,
[3]
Kelsey attended
St. Margaret's School
from 1928 to 1931 in
the provincial capital
, graduating at age 15.
[4]
From 1930 to 1931, she attended
Victoria College
(now University of Victoria). She then enrolled at
McGill University
, where she received both a B.Sc. (1934) and an M.Sc. (1935) in pharmacology.
[3]
Encouraged by one of her professors, she "wrote to EMK Geiling, M.D., a noted researcher [who] was starting up a new pharmacology department at the
University of Chicago
, asking for a position doing graduate work".
[4]
Geiling, unaware of spelling conventions with respect to Francis and Frances, presumed that Frances was a man and offered her the position, which she accepted, starting work in 1936.
[5]
[6]
During Kelsey's second year, Geiling was retained by the FDA to research unusual deaths related to
elixir sulfanilamide
, a
sulfonamide
medicine. Kelsey assisted on this research project, which showed that the 107 deaths were caused by the use of
diethylene glycol
as a
solvent
. The next year, the
United States Congress
passed the
Federal Food, Drug, and Cosmetic Act
of 1938.
[4]
That same year she completed her studies and received a Ph.D. in pharmacology at the University of Chicago.
[4]
Working with Geiling led to her interest in
teratogens
, drugs that cause
congenital malformations
(birth defects).
[7]
Early career
[
edit
]
Upon completing her Ph.D., Oldham joined the University of Chicago faculty. In 1942, like many other pharmacologists, Oldham was looking for a synthetic cure for
malaria
. As a result of these studies, Oldham learned that some drugs are able to pass through the
placental
barrier.
[8]
During her work, she also met fellow faculty member Fremont Ellis Kelsey, whom she married in 1943.
[4]
While on the faculty at the University of Chicago, Kelsey was awarded her M.D. in 1950.
[4]
She supplemented her teaching with work as an editorial associate for the
American Medical Association
Journal
for two years. Kelsey left the University of Chicago in 1954, decided to take a position teaching pharmacology at the
University of South Dakota
, and moved with her husband and two daughters to
Vermillion, South Dakota
, where she taught until 1957.
[3]
She became a
dual citizen
of Canada and the United States in the 1950s in order to continue practicing medicine in the U.S., but retained strong ties to Canada where she continued to visit her siblings regularly until late in life.
[2]
Work at the FDA and thalidomide
[
edit
]
In 1960, Kelsey was hired by the FDA in Washington, D.C. At that time, she "was one of only seven full-time and four young part-time physicians reviewing drugs"
[4]
for the FDA. One of her first assignments at the FDA was to review an application by
Richardson-Merrell
for the drug
thalidomide
(under the tradename Kevadon) as a tranquilizer and painkiller with specific indications to prescribe the drug to pregnant women for
morning sickness
. Although it had been previously approved in Canada and more than 20 European and African countries,
[9]
she withheld approval for the drug and requested
further studies
.
[3]
Despite pressure from thalidomide's manufacturer
Grunenthal
, Kelsey persisted in requesting additional information to explain observations by
Lesley Florence
of
neurological symptoms
published in the
British Medical Journal
in December 1960.
[4]
[10]
She also requested data showing the drug was not harmful to the fetus.
[10]
Kelsey's insistence that the drug should be fully tested prior to approval was vindicated when the births of deformed infants in Europe were linked to thalidomide ingestion by their mothers during pregnancy.
[11]
[12]
Researchers discovered that the thalidomide crossed the
placental
barrier and caused serious
birth defects
.
[8]
She was hailed on the front page of
The Washington Post
as a heroine
[13]
for averting a similar tragedy in the U.S.
[14]
Morton Mintz
, author of
The Washington Post
article, said
"[Kelsey]
prevented ... the birth of hundreds or indeed thousands of armless and legless children."
[13]
Kelsey insisted that her assistants, Oyama Jiro and Lee Geismar, as well as her FDA superiors who backed her strong stance, deserved credit as well. The narrative of Kelsey's persistence was used to help pass rigorous drug approval regulation in 1962.
[1]
After Mintz broke the story in July 1962, there was a substantial public outcry. The
Kefauver Harris Amendment
was passed unanimously by Congress in October 1962 to strengthen drug regulation.
[11]
[12]
Companies were required to demonstrate the efficacy of new drugs, report adverse reactions to the FDA, and request consent from patients participating in clinical studies.
[15]
The drug testing reforms required "stricter limits on the testing and distribution of new drugs"
[8]
to avoid similar problems. The amendments, for the first time, also recognized that "effectiveness [should be] required to be established prior to marketing."
[11]
[12]
As a result of her blocking American approval of thalidomide, Kelsey was awarded the
President's Award for Distinguished Federal Civilian Service
by
John F. Kennedy
on August 7, 1962,
[16]
becoming the second woman so honoured.
[17]
After receiving the award, Kelsey continued her work at the FDA. There, she played a key role in shaping and enforcing the 1962 amendments.
[14]
She also became responsible for directing the surveillance of drug testing at the FDA.
[3]
Kelsey retired from the FDA in 2005, at age 90, after 45 years of service.
[9]
In 2010, the FDA named the Kelsey Award for her, to be awarded annually to an FDA employee for "Excellence and Courage in Protecting Public Health".
[18]
Later life and death
[
edit
]
Kelsey continued to work for the FDA while being recognised for her earlier work. She was still working at the FDA's
Center for Drug Evaluation and Research
in 1995 and was appointed deputy for scientific and medical affairs. In 1994, the
Frances Kelsey Secondary School
in
Mill Bay, British Columbia
, was named in her honour.
[19]
In 2010, the FDA presented Kelsey with the first Drug Safety Excellence Award and named the annual award after her,
[20]
announcing that it would be given to one FDA staff member annually.
[21]
In announcing the awards, Center Director
Steven K. Galson
said: "I am very pleased to have established the Dr. Frances O. Kelsey Drug Safety Excellence Award and to recognize the first recipients for their outstanding accomplishments in this important aspect of drug regulation."
[22]
Kelsey
turned 100
in July 2014,
[23]
and shortly thereafter, in the fall of 2014, she moved from Washington, D.C., to live with her daughter in
London, Ontario
.
[24]
In June 2015, when she was named to the
Order of Canada
,
Mercedes Benegbi
, a thalidomide victim and the head of the Thalidomide Victims Association of Canada, praised Kelsey for showing strength and courage by refusing to bend to pressure from drug company officials, and said "To us, she was always our heroine, even if what she did was in another country."
[24]
Kelsey died in London, Ontario, on August 7, 2015, at the age of 101,
[25]
less than 24 hours after Ontario's Lieutenant-Governor,
Elizabeth Dowdeswell
, visited her home to present her with the insignia of Member of the Order of Canada for her role against thalidomide.
[26]
Legacy and awards
[
edit
]
See also
[
edit
]
References
[
edit
]
- ^
a
b
McFadden, Robert (August 7, 2015),
"Frances Oldham Kelsey, F.D.A. Stickler Who Saved U.S. Babies From Thalidomide, Dies at 101"
,
The New York Times
.
- ^
a
b
Peritz, Ingrid (November 24, 2014),
"Canadian doctor averted disaster by keeping thalidomide out of the U.S."
,
The Globe and Mail
, retrieved
August 7,
2015
.
- ^
a
b
c
d
e
"Frances Kelsey"
,
Canada Heirloom Series
, Heirloom Publishing Inc., 986
, retrieved
August 15,
2009
.
- ^
a
b
c
d
e
f
g
h
Bren, Linda (March?April 2001),
"Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History"
,
FDA Consumer
,
35
(2): 24?29,
PMID
11444245
, archived from
the original
on October 20, 2006
, retrieved
August 15,
2009
.
- ^
"When Kelsey read Geiling's letter offering her a research assistantship and scholarship in the PhD program at Chicago, she was delighted. But there was one slight problem ? one that 'tweaked her conscience a bit.' The letter began 'Dear Mr. Oldham,' Oldham being her maiden name. Kelsey asked her professor at McGill if she should wire back and explain that Frances with an 'e' is female. 'Don't be ridiculous,' he said. 'Accept the job, sign your name, put 'Miss' in brackets afterwards, and go!'" Bren (2001).
- ^
Johnson, Steven
(2021).
Extra Life
(1st ed.).
Riverhead Books
. p. 132.
ISBN
978-0-525-53885-1
.
- ^
Spiegel, Rachel,
Research in the News: Thalidomide
, archived from
the original
on August 22, 2007
, retrieved
August 15,
2009
.
- ^
a
b
c
Simpson, Joanne Cavanaugh (September 2001),
"Pregnant Pause"
,
Johns Hopkins Magazine
,
53
(4)
, retrieved
April 30,
2006
.
- ^
a
b
c
Rouhi, Maureen (June 20, 2005),
"Top Pharmaceuticals: Thalidomide"
,
Chemical & Engineering News
,
83
(25),
doi
:
10.1021/cen-v083n025.p122
, retrieved
April 30,
2006
.
- ^
a
b
Phillips, Stephen (March 9, 2020).
"How a courageous physician-scientist saved the U.S. from a birth-defects catastrophe"
.
UChicago Medicine
. Retrieved
May 6,
2020
.
- ^
a
b
c
"The Story Of The Laws Behind The Labels"
,
FDA Consumer
, June 1981, archived from
the original
on August 16, 2009
, retrieved
August 15,
2009
- ^
a
b
c
"The Story Of The Laws Behind The Labels"
,
FDA Consumer
, June 1981
, retrieved
March 15,
2022
.
- ^
a
b
Mintz, Morton (July 15, 1962), "
'Heroine' of FDA Keeps Bad Drug Off of Market",
The Washington Post
, p. Front Page
. See also
Mintz's comments from 2005
on Kelsey.
- ^
a
b
Dr. Frances Kathleen Oldham Kelsey
, National Library of Medicine
, retrieved
April 30,
2006
.
- ^
Frances Oldham Kelsey
, Chemical Heritage Foundation, archived from
the original
on July 12, 2016
, retrieved
March 23,
2014
- ^
Kennedy, John F.
(1962),
Remarks Upon Presenting the President's Awards for Distinguished Federal Civilian Service
, retrieved
May 1,
2006
.
- ^
a
b
Women of the Hall ? Frances Kathleen Oldham Kelsey, Ph.D., M.D.
, National Women's Hall of Fame, 2000, archived from
the original
on October 3, 2002
, retrieved
May 1,
2006
.
- ^
Lyndsey Layton (September 13, 2010),
"Physician to be honored for historic decision on thalidomide"
,
The Washington Post
.
- ^
FKSS History
, Frances Kelsey Secondary School, archived from
the original
on October 19, 2012
, retrieved
December 26,
2014
.
- ^
Harris, Gardiner (September 13, 2010),
"The Public's Quiet Savior From Harmful Medicines"
,
The New York Times
, retrieved
January 4,
2011
.
- ^
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs ? Remarks at the Award Ceremony for Dr. Frances Kelsey
.
- ^
Barber, Jackie (November 10, 2005),
"Center ceremony honors 107 individuals, 47 groups: Spring event inaugurates Frances Kelsey Drug Safety Award"
,
News Along the Pike
, archived from
the original
on June 15, 2007
, retrieved
August 15,
2009
.
- ^
McElroy, Justin (July 24, 2014),
Canadian scientist Frances Kelsey, who spurred FDA reforms, turns 100
,
Global News
, retrieved
July 24,
2014
.
- ^
a
b
c
Ingrid Peritz (July 1, 2015),
"Doctor who opposed thalidomide in U.S. named to Order of Canada"
,
The Globe and Mail
, retrieved
July 1,
2015
.
- ^
Bernstein, Adam; Sullivan, Patricia (August 7, 2015),
"Frances Oldham Kelsey, FDA scientist who kept thalidomide off U.S. market, dies at 101"
,
The Washington Post
, retrieved
August 7,
2015
.
- ^
Ingrid Peritz (August 7, 2015),
"Canadian doctor who kept thalidomide out of U.S. dies"
,
The Globe and Mail
, retrieved
August 7,
2015
.
- ^
Gold Key Award Recipients
, The University of Chicago The Medical & Biological Sciences Alumni Association
, retrieved
August 14,
2006
.
- ^
Geraghty, Karen (July 2001),
"Profile of a Role Model ? Frances Oldham Kelsey, MD, PhD"
,
Virtual Mentor ? American Medical Association Journal of Ethics
,
7
(7), archived from
the original
on September 29, 2007
, retrieved
August 15,
2009
.
- ^
"Foremother and Health Policy Hero Awards Luncheon"
. May 7, 2018.
- ^
"FDA honors one of its own"
.
CNN
blog
. September 16, 2010. Archived from
the original
on September 30, 2017
. Retrieved
August 9,
2015
.
- ^
"Honorary doctor of science degree from Vancouver Island University"
,
Nanaimo News Bulletin
, Black Press, Inc., June 6, 2012, archived from
the original
on June 6, 2014
, retrieved
June 27,
2012
.
Further reading
[
edit
]
- Bren, Linda (March?April 2001),
"Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History"
,
FDA Consumer
,
35
(2): 24?29,
PMID
11444245
, archived from
the original
on October 20, 2006
, retrieved
August 15,
2009
- Harris, Gardiner (September 13, 2010),
"The Public's Quiet Savior From Harmful Medicines"
,
The New York Times
.
- Harris, Steven B. (1992),
The Right Lesson to Learn from Thalidomide
, archived from
the original
on April 20, 2001
.
- Kelsey, Frances O. (1993),
Autobiographical Reflections
(PDF)
. This was drawn from oral history interviews conducted in 1974, 1991, and 1992; presentation, Founder's Day, St. Margaret's School, Duncan, B. C., 1987; and presentation, groundbreaking, Frances Kelsey School, Mill Bay, B. C., 1993.
- McGovern, James (2020), "Quieter Things: The Tale of Frances Oldham Kelsey",
Boulevard
,
35
(2 & 3): 209?219
.
- Mintz, Morton (1965),
The therapeutic nightmare; a report on the roles of the United States Food and Drug Administration, the American Medical Association, pharmaceutical manufacturers, and others in connection with the irrational and massive use of prescription drugs that may be worthless, injurious, or even lethal.
, Boston: Houghton Mifflin,
LCCN
65015156
.
Library of Congress catalog entry
.
- McFadyen, R. E. (1976), "Thalidomide in America: A Brush With Tragedy",
Clio Medica
,
11
(2): 79?93,
PMID
61093
.
- Mulliken, J. (August 10, 1962), "A Woman Doctor Who Would Not be Hurried",
Life
, vol. 53, pp. 28?9,
LCCN
37008367
.
- Perri III, Anthony J.; Hsu MD, Sylvia (2003),
"A review of thalidomide's history and current dermatological applications"
,
Dermatology Online Journal
,
9
(3): 5,
doi
:
10.5070/D35FK5W0QV
,
PMID
12952752
, retrieved
August 14,
2006
.
- Seidman, Lisa A.; Warren, Noreen (September 2002),
"Frances Kelsey & Thalidomide in the US: A Case Study Relating to Pharmaceutical Regulations"
(PDF)
,
The American Biology Teacher
,
64
(7): 495,
doi
:
10.1662/0002-7685(2002)064[0495:FKTITU]2.0.CO;2
, 7
.
- Stamato, Linda (December 17, 2012),
"Thalidomide, after fifty years: A tribute to Frances Oldham Kelsey and a call for thorough, responsible federal drug regulation and oversight"
,
NJ Voices
.
|
---|
|
1980?1989
|
---|
1981
| |
---|
1982
| |
---|
1983
| |
---|
1984
| |
---|
1986
| |
---|
1988
| |
---|
|
|
1990?1999
|
---|
1990
| |
---|
1991
| |
---|
1993
| |
---|
1994
| |
---|
1995
| |
---|
1996
| |
---|
1998
| |
---|
|
|
2000?2009
|
---|
2000
| |
---|
2001
| |
---|
2002
| |
---|
2003
| |
---|
2005
| |
---|
2007
| |
---|
2009
| |
---|
|
|
|
|
|
---|
International
| |
---|
National
| |
---|
People
| |
---|
Other
| |
---|